Yutaka Osuga

19.7k total citations · 1 hit paper
573 papers, 13.5k citations indexed

About

Yutaka Osuga is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Yutaka Osuga has authored 573 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 325 papers in Reproductive Medicine, 253 papers in Obstetrics and Gynecology and 139 papers in Immunology. Recurrent topics in Yutaka Osuga's work include Endometriosis Research and Treatment (237 papers), Uterine Myomas and Treatments (140 papers) and Reproductive System and Pregnancy (130 papers). Yutaka Osuga is often cited by papers focused on Endometriosis Research and Treatment (237 papers), Uterine Myomas and Treatments (140 papers) and Reproductive System and Pregnancy (130 papers). Yutaka Osuga collaborates with scholars based in Japan, United States and United Kingdom. Yutaka Osuga's co-authors include Kaori Koga, Yuji Taketani, Yasushi Hirota, Tomoyuki Fujii, Tetsuya Hirata, Tetsu Yano, Osamu Yoshino, Miyuki Harada, Osamu Tsutsumi and Osamu Wada‐Hiraike and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Yutaka Osuga

540 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management

2015 281 citations Yutaka Osuga et al. profile →

Peers

Countries citing papers authored by Yutaka Osuga

Since Specialization

Citations

This map shows the geographic impact of Yutaka Osuga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Osuga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Osuga more than expected).

Fields of papers citing papers by Yutaka Osuga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Osuga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Osuga. The network helps show where Yutaka Osuga may publish in the future.

Co-authorship network of co-authors of Yutaka Osuga

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Osuga. A scholar is included among the top collaborators of Yutaka Osuga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Osuga. Yutaka Osuga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of a novel pain management device, AT-04, for endometriosis-related pain: study protocol for a phase III randomized controlled trial 2024 ·Reproductive Health ·Hiroshi Ishikawa, Osamu Yoshino, Fuminori Taniguchi, Tasuku Harada, Mikio Momoeda, Yutaka Osuga, (unknown), (unknown), (unknown), Yosuke Inaba, Hideki Hanaoka, Kaori Koga	1
2	Impact of human papillomavirus types on uterine cervical neoplasia 2024 ·Journal of obstetrics and gynaecology research ·Ayumi Taguchi, (unknown), (unknown), (unknown), Akira Kawata, Yuichiro Miyamoto, (unknown), Kenbun Sone, Yasushi Hirota, Yutaka Osuga	1
3	Altered release of thrombomodulin and HMGB1 in the placenta complicated with preeclampsia 2024 ·Placenta ·(unknown), Takeshi Nagamatsu, Takayuki Iriyama, Yutaka Osuga	4
4	Androgen-induced exosomal miR-379-5p release determines granulosa cell fate: cellular mechanism involved in polycystic ovaries 2023 ·Journal of Ovarian Research ·Reza Salehi, Brandon A. Wyse, Meshach Asare-Werehene, (unknown), (unknown), Bo Pan, Yoko Urata, Alex Gutsol, Jose L. Viñas, Sahar Jahangiri, Kai Xue, (unknown), Kevin D. Burns, Barbara C. Vanderhyden, Julang Li, Yutaka Osuga, Dylan Burger, Seang Lin Tan, Clifford Librach, Benjamin K. Tsang	10
5	A successful management of refractory immune thrombocytopenic purpura with Eltrombopag during pregnancy complicated with superimposed preeclampsia 2023 ·Oxford Medical Case Reports ·(unknown), Seisuke Sayama, Takayuki Iriyama, Kumi Nakazaki, (unknown), (unknown), Keiichi Kumasawa, Takeshi Nagamatsu, Mineo Kurokawa, Yutaka Osuga	1
6	The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma 2023 ·Journal of Gynecologic Oncology ·(unknown), Kenbun Sone, Katsuhiko Noda, (unknown), Shimpei Kato, (unknown), Ayumi Taguchi, Ryo Kurokawa, Yutaka Osuga	3
7	Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study 2023 ·Reproductive Medicine and Biology ·Yutaka Osuga, (unknown), (unknown), Ken Ishitani	3
8	Upregulation of autotaxin by oxidative stress via Nrf2 activation: A novel insight into the compensation mechanism in preeclamptic placenta 2023 ·Journal of Reproductive Immunology ·(unknown), Takeshi Nagamatsu, Makoto Kurano, (unknown), Ayumi Taguchi, (unknown), Mari Ichinose, Keiichi Kumasawa, Takayuki Iriyama, Tomoyuki Fujii, Yutaka Yatomi, Yutaka Osuga	3
9	The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia 2023 ·Case Reports in Obstetrics and Gynecology ·(unknown), T. Fujii, Keiichi Kumasawa, Mari Ichinose, (unknown), Seisuke Sayama, (unknown), Takayuki Iriyama, Takeshi Nagamatsu, Yutaka Osuga	0
10	Assisted reproductive technology in Japan: A summary report for 2021 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology 2023 ·Reproductive Medicine and Biology ·Yukiko Katagiri, Seung Chik Jwa, Akira Kuwahara, Takeshi Iwasa, (unknown), Keiichi Kato, Hiroshi Kishi, Yoshimitsu Kuwabara, Fuminori Taniguchi, Miyuki Harada, Akira Iwase, Yutaka Osuga	17
11	How does adenomyosis impact endometrial receptivity? An updated systematic review of clinical and molecular insights 2022 ·Takehiro Hiraoka, Yasushi Hirota, Yutaka Osuga	8
12	Postpartum degeneration of adenomyosis with diffuse cyst‐like changes and localized hemorrhage detected by sequential magnetic resonance imaging 2022 ·Journal of obstetrics and gynaecology research ·Mari Ichinose, Takayuki Iriyama, Seisuke Sayama, (unknown), (unknown), Kenbun Sone, Keiichi Kumasawa, Takeshi Nagamatsu, Shouhei Hanaoka, Yutaka Osuga	2
13	Introduction of minimally invasive surgery for the treatment of endometrial cancer in Japan: a review 2021 ·European Journal of Gynaecological Oncology ·Yuichiro Miyamoto, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori‐Uchino, Tetsushi Tsuruga, Yutaka Osuga, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
14	Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study 2021 ·Fertility and Sterility ·Tasuku Harada, Yutaka Osuga, Yusuke Suzuki, (unknown), (unknown), Jo Kitawaki	34
15	Suppression of human trophoblast syncytialization by human cytomegalovirus infection 2021 ·Placenta ·(unknown), Takeshi Nagamatsu, Kazuki Morita, Ayumi Taguchi, Takashi Toya, Keiichi Kumasawa, Takayuki Iriyama, Kei Kawana, Naoki Inoue, Tomoyuki Fujii, Yutaka Osuga	13
16	Comprehensive immunohistochemical analysis of the gastrointestinal and Müllerian phenotypes of 139 ovarian mucinous cystadenomas 2020 ·Human Pathology ·(unknown), Daichi Maeda, Aya Shinozaki‐Ushiku, Akiteru Goto, Katsutoshi Oda, Yutaka Osuga, Tomoyuki Fujii, Tetsuo Ushiku, Masashi Fukayama	14
17	Assisted reproductive technology in Japan: A summary report for 2018 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology 2020 ·Reproductive Medicine and Biology ·Osamu Ishihara, Seung Chik Jwa, Akira Kuwahara, Yukiko Katagiri, Yoshimitsu Kuwabara, Toshio Hamatani, Miyuki Harada, Yutaka Osuga	35
18	A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients 2019 ·Journal of obstetrics and gynaecology research ·(unknown), Miyuki Harada, Chisato Kunitomi, (unknown), Gentaro Izumi, Tetsuya Hirata, Tomoyuki Fujii, Nao Suzuki, Ken‐ichirou Morishige, Daisuke Aoki, Minoru Irahara, Koichiro Tsugawa, Mitsune Tanimoto, Hiroyuki Nishiyama, Hajime Hosoi, Kazuhiko Sugiyama, Akira Kawai, Yutaka Osuga	16
19	Placental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsia 2019 ·American Journal of Reproductive Immunology ·T. Fujii, Takeshi Nagamatsu, Danny J. Schust, (unknown), Keiichi Kumasawa, Shinichiro Yabe, Takayuki Iriyama, Yasushi Hirota, Yutaka Osuga, Junken Aoki, Yutaka Yatomi, Tomoyuki Fujii	11
20	Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors 1997 ·Molecular Endocrinology ·Yutaka Osuga, Masataka Kudo, Antti Kaipia, Brian K. Kobilka, Aaron J.W. Hsueh	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact